期刊文献+

甲型流感病毒DNA疫苗双表达载体的构建及表达 被引量:1

Construction and expression of DNA vaccine coexpression vector of influenza A virus
在线阅读 下载PDF
导出
摘要 目的:构建含有甲型流感病毒M2基因与GM-CSF基因的DNA疫苗双表达载体,为研究甲型通用流感疫苗奠定基础。方法:将甲型流感病毒(H1N1)接种鸡胚后收获尿囊液,提取流感病毒总RNA,RT-PCR法扩增M2基因;将微小病毒内部核糖体进入位点(IRES)基因插入到质粒pVAXⅠ多克隆位点,再将M2基因和GM-CSF基因依次克隆到IRES的上、下游多克隆位点,构建出甲型流感病毒双表达载体pMIG,酶切鉴定后测序;脂质体法转染COS7细胞并检测目的蛋白的表达。结果:成功扩增出M2基因(约300bp)、IRES基因(约580bp)和GM-CSF基因(约400bp),酶切鉴定结果表明构建出甲型流感病毒双表达载体pMIG,Western blotting检测证明流感病毒M2蛋白的表达。结论:成功构建出流感病毒DNA疫苗双表达载体pMIG。 Objective To construct the DNA vaccine coexpression vector containing M2 gene of influenza A virus and GM-CSF gene, which provides a basis for exploring broad-spectrum vaccine of influenza A virus. Methods Analogous strain of influenza A virus (H1N1) was inoculated by chicken and alantoic fluid was collected, the total RNA of influenza A virus was extracted, M2 gene was amplified by RT-PCR. Internal ribosome entry site (IRES) gene of minute virus was inserted into the multiple cloning sites (MCS) of the plasmid pVAX I , then M2 gene and GM-CSF gene were in turns cloned into the MCS of the advanced and backward MCS of IRES for constructing pMIG-the coexpression vector of influenza A virus and sequencing after enzymetomy identification. Then the recombinant plasmid pMIG was transfected into COS7 cell by liposome method and the expression of the target protein was detected. Results M2 gene (300 bp), IRES gene (580 bp) and GM-CSF gene (400 bp) were successfully amplified, the result of enzymetomy identification indicated that the coexpression vector pMIG of influenza A virus was constructed, Western blotting testified that M2 protein of influenza A virus was expressed. Conclusion The coexpression vector pMIG of influenza A virus is successfully constructed.
出处 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2008年第1期65-68,共4页 Journal of Jilin University:Medicine Edition
基金 吉林省科技厅基金资助课题(200505184)
关键词 流感病毒A型 M2基因 DNA疫苗 influenza A virus M2 gene DNA vaccine
  • 相关文献

参考文献6

  • 1李海山,刘勇,邵一鸣.DNA疫苗及其优化策略[J].国外医学(病毒学分册),2003,10(3):74-78. 被引量:1
  • 2Wild J,Gruner B,Metzger K,et al.Polyvatent vaccination against hepatitis B surface andcore antigen using a dicistronic expression plasmid[J].Vaccine,1998,16:353-360.
  • 3De Jong JC,Beyer WE,Palache AM,et al.Mismatch between the 1997/1998 influenza vaccine and the major epidemic A (H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly[J].J Med Virol,2000,61 (1):94-98.
  • 4任志霞,赵大鹏.基因工程乙肝疫苗研究进展[J].预防医学论坛,2006,12(3):325-329. 被引量:4
  • 5Bardiya N,Bae JH.Influenza vaccines; resent advances in production technologies[J].Appl Microbiol Biotechnol,2005,67 (3):299-305.
  • 6Fiers W,De Filette M,Birkett A,et al.A "universal"human influenza A vaccine[J].Virus Res,2004,103 (1-2):173-176.

二级参考文献74

共引文献3

同被引文献8

  • 1Bardiya N, Bae JH. Influenza vaccines: resent advances in production technologies. Appl Microbiol Biotechnol, 2005, 67 (3): 299 - 305.
  • 2Sambrook J, Russell DW. Molecular cloning: a laboratory manual, 3rd ed. New York: Cold Spring Harbor Laboratory Press, 2001.32 -52.
  • 3沈关心,周汝麟.现代免疫学实验技术.第2版.湖北:科学技术出版社,2002.
  • 4Stephenson I, Nicholson KG. Influenza: vaccination and treatment. Eur Respir J , 2001, 17 : 1282 - 1293.
  • 5Nichol KL. The efficacy, effectiveness and cost - effectiveness of inactivated influenza virus vaccines. Vaccine, 2003, 21 (16) : 1769 - 1775.
  • 6Ruben FL. Inactivated influenza virus vaccines in children. Clin Infect Dis, 2004, 38 (5): 678-688.
  • 7张连霞,何韶衡.人粒细胞-巨噬细胞集落刺激因子生物学特性及其与变态反应性疾病关系的研究新进展[J].临床和实验医学杂志,2008,7(5):166-169. 被引量:2
  • 8张洪利,王金香,康大力.DNA疫苗的作用机制及影响因素[J].现代医药卫生,2008,24(11):1651-1652. 被引量:1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部